Pacific Biomarkers (United States)

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

• Medicine 4.3×
• Biochemistry, Genetics and Molecular Biology 3.2×

By fractional works in all years, weighted toward what it does more of than the world: Metabolic Syndrome, Cholesterol, Cardiovascular Disease, Obesity, Insulin Resistance, Atherosclerosis, Statins and Diabetes.

By volume in 2022–2025: Genetic factors in colorectal cancer, Cancer Risks and Factors, Colorectal Cancer Screening and Detection and Breast Cancer Treatment Studies.

1. 1 Genetic factors in colorectal cancer Pathology and Forensic Medicine 0 works
2. 2 Cancer Risks and Factors Oncology 0 works
3. 3 Colorectal Cancer Screening and Detection Oncology 0 works
4. 4 Breast Cancer Treatment Studies Cancer Research 0 works
5. 5 Obesity, Physical Activity, Diet Public Health, Environmental and Occupational Health 0 works
6. 6 Pancreatic and Hepatic Oncology Research Oncology 0 works
7. 7 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 0 works
8. 8 Cancer Genomics and Diagnostics Cancer Research 0 works
9. 9 Nutritional Studies and Diet Public Health, Environmental and Occupational Health 0 works
10. 10 Global Cancer Incidence and Screening Oncology 0 works

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

Output in 2018–2022 was 15% lower than in 2013–2017.

• University of Washington
• Seattle University
• Fred Hutch Cancer Center
• University of Washington Medical Center
• University of Washington Applied Physics Laboratory
• Seattle Children's Hospital
• Amazon (United States)
• Virginia Mason Medical Center